Sanjivani Paranteral Ltd

Sanjivani Paranteral Ltd (SANJIVIN) is a micro-cap Healthcare company valued at ₹212 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Sanjivani Paranteral Ltd last traded at ₹172, modestly down 1.15% on the day.

Recent developments

On 2026-06-30, promoter holding increased by 0.30 percentage points to 31.56%, signaling a small boost in ownership. Domestic institutional holding decreased by 0.59 percentage points to 5.45% in the same period. The company's latest quarter results showed improved profitability compared to the year-ago quarter, with both revenue and net profit growing significantly.

Financial performance

The company's annual revenue fell 2.0% to ₹69 crore, while annual net profit dropped 17.3% to ₹7 crore. The latest quarter saw revenue rise 33.3% to ₹24 crore and net profit increase 43.9% to ₹2 crore compared to the same quarter a year earlier, though the net profit margin narrowed 1.8 percentage points to 9.7%.

Valuation multiples

The stock trades at 31.3 times earnings, broadly in line with the Healthcare median of 32.0, 4.60 times book value. It yields 0.3%.

Things to watch

The company's annual net profit fell 17.3% year-over-year, and the net profit margin declined 1.8 percentage points to 9.7%. The stock is 28.7% below its 52-week high, and domestic institutional holding dropped to 5.45% in the latest quarter.

Where it stands

Sanjivani Parenteral Ltd reported a decline in annual net profit and a narrowing margin, but the latest quarter showed strong growth in both revenue and net profit. The stock is trading 28.7% below its 52-week high, and promoter holding increased slightly in the latest quarter.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.